Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $75.8B
1-Year Est. Return 50.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Quarter Est. Return
1 Year Est. Return
+50.56%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$75.8B
AUM Growth
+$582M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
4,038
New
Increased
Reduced
Closed

Top Buys

1 +$633M
2 +$487M
3 +$419M
4
META icon
Meta Platforms (Facebook)
META
+$345M
5
KO icon
Coca-Cola
KO
+$257M

Top Sells

1 +$1.36B
2 +$900M
3 +$583M
4
NVDA icon
NVIDIA
NVDA
+$335M
5
NFLX icon
Netflix
NFLX
+$320M

Sector Composition

1 Technology 21.72%
2 Healthcare 15.16%
3 Consumer Discretionary 11.8%
4 Communication Services 10.53%
5 Financials 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IFBD icon
3826
Infobird
IFBD
$8.01M
-10,100
IGF icon
3827
iShares Global Infrastructure ETF
IGF
$8.98B
-64,900
IGMS
3828
DELISTED
IGM Biosciences
IGMS
-117,734
BRSL
3829
Brightstar Lottery PLC
BRSL
$2.84B
-37,500
IIIV icon
3830
i3 Verticals
IIIV
$658M
-12,000
IIPR icon
3831
Innovative Industrial Properties
IIPR
$1.42B
-4,400
IJJ icon
3832
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.34B
-7,800
IJK icon
3833
iShares S&P Mid-Cap 400 Growth ETF
IJK
$9.54B
-2,300
IJT icon
3834
iShares S&P Small-Cap 600 Growth ETF
IJT
$6.57B
-5,900
IMCG icon
3835
iShares Morningstar Mid-Cap Growth ETF
IMCG
$3.19B
-3,800
IMNN icon
3836
Imunon
IMNN
$12.5M
-48,913
IMO icon
3837
Imperial Oil
IMO
$44.9B
-29,195
IMVT icon
3838
Immunovant
IMVT
$5.24B
-241,400
IMXI icon
3839
International Money Express
IMXI
$460M
-125,800
INBS icon
3840
Intelligent Bio Solutions
INBS
$21.8M
-1,090
INZY
3841
DELISTED
Inozyme Pharma
INZY
-470,500
IOT icon
3842
Samsara
IOT
$19.4B
-931,162
IOVA icon
3843
Iovance Biotherapeutics
IOVA
$973M
-4,887,200
IQV icon
3844
IQVIA
IQV
$41.3B
-103,047
ITOS
3845
DELISTED
iTeos Therapeutics
ITOS
-602,100
IVE icon
3846
iShares S&P 500 Value ETF
IVE
$49.2B
-4,100
IVOO icon
3847
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.1B
-7,600
IVV icon
3848
iShares Core S&P 500 ETF
IVV
$774B
-1,200
IVW icon
3849
iShares S&P 500 Growth ETF
IVW
$67.3B
-37,700
IVZ icon
3850
Invesco
IVZ
$12.7B
-442,600